Kyorin Holdings Inc
TSE:4569
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Kyorin Holdings Inc
Net Income (Common)
Kyorin Holdings Inc
Net Income (Common) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Kyorin Holdings Inc
TSE:4569
|
Net Income (Common)
¥10.8B
|
CAGR 3-Years
23%
|
CAGR 5-Years
11%
|
CAGR 10-Years
-2%
|
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Net Income (Common)
¥112.9B
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Net Income (Common)
¥304.6B
|
CAGR 3-Years
72%
|
CAGR 5-Years
34%
|
CAGR 10-Years
-1%
|
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Net Income (Common)
¥363.2B
|
CAGR 3-Years
39%
|
CAGR 5-Years
20%
|
CAGR 10-Years
14%
|
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Net Income (Common)
¥452.2B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
17%
|
CAGR 10-Years
22%
|
|
|
Astellas Pharma Inc
TSE:4503
|
Net Income (Common)
¥322.9B
|
CAGR 3-Years
33%
|
CAGR 5-Years
18%
|
CAGR 10-Years
6%
|
|
Kyorin Holdings Inc
Glance View
KYORIN Holdings, Inc. engages in the development, manufacture and sale of pharmaceutical products through its subsidiaries. The company is headquartered in Chiyoda-Ku, Tokyo-To and currently employs 2,243 full-time employees. The company went IPO on 2006-03-10. The firm operates through two business segments. The Pharmaceuticals segment is engaged in the manufacture, purchase and sales of pharmaceutical products, the evaluation of technologies, the inspection, analysis and negotiation of license affiliations, as well as the research of new drugs and candidate compounds. The company also engages in the purchase and sales of medical promotion tools and packaging materials. The Healthcare segment is engaged in the manufacturing, sales and purchase of environmental sanitation products, general purpose medicines and skin care products.
See Also
What is Kyorin Holdings Inc's Net Income (Common)?
Net Income (Common)
10.8B
JPY
Based on the financial report for Dec 31, 2025, Kyorin Holdings Inc's Net Income (Common) amounts to 10.8B JPY.
What is Kyorin Holdings Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
-2%
Over the last year, the Net Income (Common) growth was 180%. The average annual Net Income (Common) growth rates for Kyorin Holdings Inc have been 23% over the past three years , 11% over the past five years , and -2% over the past ten years .
